Sign In

Prof. Yechezkel Barenholz will receive the prestigious 2020 EMET Prize in Nanotechnology

The Faculty of Medicine congratulates Professor Yechezkel (Hezi) Barenholz from the School of Medicine and the Institute for Medical Research Israel-Canada (IMRIC) on receiving the prestigious EMET Prize.
Barenholz’s current research focuses on the development of liposome-based nano drugs, as best exemplified by the anticancer drug Doxil®, the first nano drug approved by the FDA (1995) with over 700,000 cancer patients treated so-far worldwide. Three of Barenholz’s other liposomal nano-drugs (for osteoarthritis, resistant-bacteria, and inflammation) are now in clinical trials.
The EMET Prize is given annually to exceptional Israelis for excellence in academic and professional achievements that have far reaching influence and significant contribution to society.
The Prize is given by the A.M.N. Foundation for the Advancement of Science, Art and Culture in Israel, under the auspices of and in cooperation with the Prime Minister of Israel.
Link to the EMET Prise website
Chezi Barenholz ant EMET prize logo